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The AKT8 virus was isolated from a spontaneous thymic lymphoma of an
AKR mouse (1) . It produces foci of malignant transformation in vitro and is
defective, requiring helper virus for propagation . TheAKT8 proviralDNA was
cloned and shown to contain cell-derived sequences termed akt, substituting for
a portion of the virus genome (2). akt was designated an oncogene based on the
ability of the AKT8 virus to transform cells in vitro and the finding ofa tumor-
specific amplification of theAKTI gene (an homologous allele identified in man)
in a human gastric adenocarcinoma . We have now examined the ability of the
AKT8 virus to produce tumors in mice, and find that it induces thymic lympho-
mas in two and possibly the third of the three strains tested . TheAKT8 virus is
thus tumorigenic in vivo, further confirming the oncogenic potential of the akt
gene .
Material and Methods
Cells and Virus. The AKT8-transformed, nonproducer mink(AKT8)cll cell line, a
subclone of mink(AKT8) (1), wasused to prepare pseudotypes ofAKT8 virus by infection
with either the 1504A or 4070A strains of amphotropic murine leukemia virus (MuLV)
(3, 4) . The preparation of virus stocks, tissue extract, and titration of transforming and
helper virus were as previously described (5-7). Pools of AKT8(1504A) and
AKT8(4070A) titered 104 focus forming units per milliliter on mink lung cells (MiLu,
ATCC CCL 64) ; helper virus titers were 30-100-fold higher.
Tumorigenicity Assay.
￿
AKR/J mice were obtained from TheJackson Laboratory, Bar
Harbor, ME, and AKR/N and NFS mice from the National Institutes of Health animal
facility . [NFS X NS.C58V1]F, mice were the progeny of NFS females and males of an
NFS strain congenic for an endogenous ecotropic MuLV ofthe C58/Lw mouse strain (8).
AKR, NFS, and [NFS X NS.C58vl]F l mice were inoculated when 1-2 d old with 0.04 ml
of virus divided intrathymically and intraperitoneally and observed for a minimum of 6
mo (AKR) or 9 mo (NFS and [NFS X NS.C58V1]F,) . Animals that appeared ill were
autopsied to confirm the presence of thymic lymphoma grossly and, in selected cases,
microscopically .
DNA Analysis.
￿
Extraction of DNA from tissues and Southern blot analysis were as
previously described (2) . To detect the AKT8 virus we used the pvakt/1 probe (2) which
contains cell-derived akt sequences but does not hybridize with any endogenous retrovirus
genes in the mouse .
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TABLE I
Tumor Induction by AKT8 Virus
* Mouse from which theNFS thymic lymphoma extract (NFS TL EXTR.) was prepared.
Results
Initial attempts to establish the in vivo oncogenicity of the AKT8 virus (1)
were limited by several factors: (a) the use of a MCF helper virus which, due to
the production of cytopathic foci on MiLu cells, obscured the transforming titer
ofAKT8; (b) the ability of MCF alone to accelerate thymic lymphomas in AKR
mice (5, 7); and (c) the deletional inactivation of the AKT8 provirus in the
original mink (AKT8) cell clone (2) resulting in reduced titers of AKT8. We
have now reexamined the invivo pathogenicity oftheAKT8 virus withimproved
reagents, using helper viruses and mouse strains selected to overcome possible
masking of the biological effect ofthe AKT8 virus.
To minimize tumor induction by helper virus, and to allow assay oftransform-
ing virus titers without interference by cytopathic foci on MiLu cells, the poorly
leukemogenic amphotropic MuLV strains 1504A and 4070A were chosen to
rescue the AKT8 genome. Mink(AKT8)cll cells, which yield 10-fold higher titers
ofAKT8 than mink(AKT8), were used to prepare the virus pools. To provide
the high endogenous ecotropic MuLV background found to be required for
tumor induction by certain oncogenic MuLVs (9), we selected for inoculation
the high-virus strains AKR, in which thymic lymphoma occurs at high frequency,
and [NFS X NS.C58VI]F,, in which spontaneous lymphomas and leukemias are
rare before 1 yr of age (10). Ecotropic MuLV- NFS mice, a strain with a low
incidence of spontaneous neoplasms, were also inoculated.
The incidence of tumors in the inoculated mice is shown in Table 1. All the
AKR mice inoculated with AKT8(1504A) developed tumors with an average
delay of 120 d (range 80-178 d). Only one of the control mice developed a
tumor at 192 d. Since AKR mice only begin to develop thymic lymphomas at
^-6 mo of age, inoculation with AKT8(1054A) resulted in at least a 2-mo
acceleration ofthe disease. Tumors developed in 60% ofthe [NFS X NS.C58V1]
F, mice with a latency of 139 d (range 84-236 d), whereas no tumors were
Virus Mouse Lymphoma/total Positive
Days
to
disease
AKT8
sequences
present in tumor
AKT8 (1504A) AKR 13/13 100 120 9/9
1504A 1/16 6 192
AKT8 (4070A) 3/3 100 120 1/1
4070A 2/7 29 154 0/1
NFS TL EXTR. 3/6 50 130 3/3
AKT8 (1504A) [NFS x NS.C58V1]V1 6/10 60 139 4/4
1504A 0/6 0
AKT8 (4070A) 2/7 29 238
4070A 0/8 0
NFS TL EXTR. 7/7 100 88 3/3
AKT8 (4070A) NFS 1*/6 17 141 1/1
4070A 1/6 17 165 0/1
NFS TL EXTR. 1/4 25 84 0/1STAAL AND HARTLEY
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FIGURE 1 . Southern blot-
ting analysis of some AKT8-
inducedtumors . The marks to
the left of the blots indicate
restriction enzyme fragments
recognized because of cross-
reactivity between the viral akt
probe and the cellular akt
proto-oncogene(s). The 3.1-
kbpmarker shows the position
of the internal fragment char-
acteristic of the AKTS virus .
The mouse/virus combina-
tions are as follows : (Lane A)
NFS/4070A, (lanes B, F, and
G) AKR/NFS thymic lym-
phoma extract, (C) NFS/NFS
tl extr ., (D and E) [NFS X
NS.C58V1]F I/NFS tl extr .
The other 16 AKTS-induced
tumors similarly hadthe char-
acteristic 3.1-kbp Pst I AKTS
fragment and a variable num-
ber of extra Eco RI bands .
The possible reason for the
altered mobility of the bands
in lane B of the Pst I analysis
are explained in the text .
observed in the control group . Spontaneous thymic lymphomas occur rarely, if
ever, in these mice (10 and Hartley, J.W ., unpublished data). The results with
AKT8(4070A) virus were generally consistent with those obtained with
AKT8(1504A), but suggest that this pseudotype was less efficient in inducing or
accelerating neoplasia .
Southern blot analysis of some of the tumors is presented in Fig. 1 and
reported in total in Table I. The 3.1-kbp Pst I fragment characteristic of the
AKT8 provirus was seen in all of the tested tumors, but not in nontumor tissue,
developing in AKT8(1504)and AKT8(4070A)inoculated mice . The two tumors
examined that developed in mice inoculated with helper virus alone lacked any
fragments other than those due to hybridization with the akt proto-oncogene(s) .
Analysis with Eco RI demonstrated from one to five unique integrations of the
AKT8 provirus in each tumor DNA . Since Eco RI cuts in the flanking cellular
sequences but not in theAKT8 provirus, this result also demonstrates, given the
randomness of retrovirus integration into chromosomes, the clonal, or possible
oligoclonal, origin of these tumors .
Only a single tumor was observed in the six NFS mice inoculated with
AKT8(4070A) . Analysis of the DNA from this tumor, however, revealed the
clonal presence of the AKT8 genome . An extract of this tumor was prepared
and inoculated into both AKR and [NFS X NS.C58V1]F, mice . As shown in
Table I, this extract was highly leukemogenic in [NFS X NS.C58V1]F, mice,
producing tumors in all of the seven animals inoculated with a latency of 88 d
(range 51-160 d) . All three of the tumors developing in the AKR mice, and
three of the three [NFS X NS.C58V1]F, tumors tested, contained the AKT8
genome . The tumor extract contained MCF virus ; it is likely that the presence1262
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of this leukemogenic helper virus allowed the more rapid entry of the AKT8
genome into thymic tissue, and the shortened latency to tumor development, in
the [NFS x NS.C58V1]F, mice. MCF virus alone induces tumors in these mice.
In a separate study, 67% of mice inoculated with AKR MCF 247 MuLV
developed tumors at a mean of 85 d (Hartley, J. W., unpublished observations).
The clonal presence of the AKT8 genome in the current tumors, however,
demonstrates a direct role for the AKT8 virus in their induction.
One of the tumors developing in an AKR mouse lacked the 3.1-kbp Pst I
fragment, but contained three extra fragments of differing mobility (Fig. 1, Pst
1, lane B). These variant fragments are probably the result of recombination
within the envelope gene between AKT8 and other retrovirus genomes that
remove or introduce Pst I restriction enzyme sites into the AKT8 provirus.
Discussion
The more rapid and frequent induction of thymic lymphomas in susceptible
mouse strains by the AKT8 virus, in combination with the exact correlation
between inoculation with the AKT8 virus and the presence of AKT8 provirus
in the DNA of the subsequent tumor, provides in vivo evidence of the oncogen-
icity of this virus and its oncogene, akt. These data also support the potential of
the cellular akt proto-oncogene to contribute to malignant transformation.
Whether the AKT8 virus alone is capable of malignant transformation of
thymocytes is unclear from these experiments; its transforming activity could be
further analyzed by attempts to transform thymocytes or other primary cells in
vitro, or by the creation of a transgenic mouse strain carrying the tumorigenic
akt gene. Although the AKT8 virus can directly transform a mink lung epithelial
cell line in vitro, further genetic changes affecting other cellular genes, or
additional retrovirus interactions with the cell, are likely to be necessary for final
malignant transformation of normal tissue.
The thymic lymphoma that develops in AKR mice (11, 12) results from a
perinatal and persistent viremia (13) consequent to the activation of one or more
of the ecotropic MuLV loci inherited as Mendelian elements in this strain (14).
During the 6 mo before tumors begin to appear there is recombination between
the poorly leukemogenic ecotropic MuLV and other endogenous retrovirus
genes present in these mice (5, 15, 16), which generates highly leukemogenic
MCF or polytropic viruses. These recombinant viruses may be, in part, more
leukemogenic due to an increased ability to infect thymocytes (17). Several
groups have demonstrated chromosomal insertion of the MCF provirus in the
vicinity of the myc oncogene in a significant percentage of AKR thymic lympho-
mas (18-22). Repeated virus integration in different chromosomal locations has
also been documented in other retrovirus-induced thymic lymphomas. The loci
in the vicinity of these integrations are thought to be potentially oncogenic and
have been designated pim-1 (23), Mlvi-1, Mlv-2, Mlv-3 (24), mis-1/pvt-1 (25), and
Dsi-1 (26). The akt gene is unrelated to myc and other viral oncogenes as
determined by crosshybridization of DNA (2), and the chromosome location of
the akt proto-oncogene does not match that of any of the above putative
oncogenes (Staal, S., and C. Kozak, unpublished data). Thus, the akt proto-
oncogene may not be involved in the pathogenesis of most spontaneous AKRSTAAL AND HARTLEY
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thymic lymphomas, or it may be involved by less easily detected point mutation,
altered regulation, or virus integration events occurring at a distance. It should
now be possible, using molecular clones of akt, to determine whether alteration
of the akt proto-oncogene is a factor in the development of the spontaneous
AKR thymic lymphoma, as well as other murine tumors.
Summary
The directly transforming murine retrovirus, AKT8, was isolated from a
spontaneous AKR thymoma and carries the cell-derived viral oncogene, akt. We
have now shown that this virus produces thymic lymphomas after inoculation of
susceptible mouse strains. The presence of the AKT8 genome in the DNA of
the virus-induced tumors was demonstrated by Southern blotting using an akt-
specific probe. These results establish the in vivo pathogencity of the AKT8
virus and its akt oncogene, and imply a potential role for the cellular akt proto-
oncogene in tumor development.
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